Indacaterol (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Indacaterol" in Vietnamese language version.

refsWebsite

Global rank Vietnamese rank

4^th place

7^th place

2^nd place

447^th place

625^th place

6^th place

4^th place

archive.org

Cazzola M, Matera MG, Lötvall J (tháng 7 năm 2005). “Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease”. Expert Opin Investig Drugs. 14 (7): 775–83. doi:10.1517/13543784.14.7.775. PMID 16022567.
Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A (tháng 5 năm 2007). “Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma”. Eur. Respir. J. 29 (5): 871–8. doi:10.1183/09031936.00060006. PMID 17251236.
Feldman, G; Siler, T; Prasad, N; Jack, D; Piggott, S; Owen, R; Higgins, M; Kramer, B; Study Group, I (2010). “Efficacy and safety of indacaterol 150 mcg once-daily in COPD: a double-blind, randomised, 12-week study”. BMC Pulmonary Medicine. 10: 11. doi:10.1186/1471-2466-10-11. PMC 2848004. PMID 20211002.
Dahl R; Chung KF; Buhl R; và đồng nghiệp (tháng 6 năm 2010). “Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD”. Thorax. 65 (6): 473–9. doi:10.1136/thx.2009.125435. PMID 20522841.
Geake, James B (2015). “Indacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary disease”. Reviews. 1: CD010139. doi:10.1002/14651858.CD010139.pub2. PMC 6464646. PMID 25575340.

“FDA approves Arcapta Neohaler to treat chronic obstructive pulmonary disease” (Thông cáo báo chí). U.S. Food and Drug Administration. 1 tháng 7 năm 2011. Truy cập ngày 2 tháng 7 năm 2011.

Cazzola M, Matera MG, Lötvall J (tháng 7 năm 2005). “Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease”. Expert Opin Investig Drugs. 14 (7): 775–83. doi:10.1517/13543784.14.7.775. PMID 16022567.
Beeh KM, Derom E, Kanniess F, Cameron R, Higgins M, van As A (tháng 5 năm 2007). “Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma”. Eur. Respir. J. 29 (5): 871–8. doi:10.1183/09031936.00060006. PMID 17251236.
Feldman, G; Siler, T; Prasad, N; Jack, D; Piggott, S; Owen, R; Higgins, M; Kramer, B; Study Group, I (2010). “Efficacy and safety of indacaterol 150 mcg once-daily in COPD: a double-blind, randomised, 12-week study”. BMC Pulmonary Medicine. 10: 11. doi:10.1186/1471-2466-10-11. PMC 2848004. PMID 20211002.
Dahl R; Chung KF; Buhl R; và đồng nghiệp (tháng 6 năm 2010). “Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD”. Thorax. 65 (6): 473–9. doi:10.1136/thx.2009.125435. PMID 20522841.
Geake, James B (2015). “Indacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary disease”. Reviews. 1: CD010139. doi:10.1002/14651858.CD010139.pub2. PMC 6464646. PMID 25575340.